Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus

Journal of Rheumatology

Volumn 25, Issue 8, 1998, Pages 1515-1519

  Meier, Christoph R ^a   Sturkenboom, Miriam C J M ^b   Cohen, Alan S ^c   Jick, Hershel ^d  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Dept of Medicine in Rheumatology ^*

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Discoid lupus erythematosus; Estrogen replacement therapy; Estrogens; Postmenopause; Progestational hormones; Systemic lupus erythematosus

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RISK FACTORS;

EID: 0031881090     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
2. Hahn BH. Systemic lupus erythematosus. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, editors. Principles of internal medicine. 12th ed. New York: McGraw-Hill; 1991:1432-7.
3. Boumpas DT, Austin HA III, Fessier BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995;122:940-50.
4. Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. II: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995;123:42-53.
5. Lahita RG. The importance of estrogens in systemic lupus erythematosus. Clin Immunol Immunopathol 1992;63:17-8.
6. Alarcon-Segovia D. The pathogenesis of immune dysregulation in systemic lupus erythematosus. A troika. J Rheumatol 1984;11: 588-90.
7. Ahmed SA, Talal N. Importance of sex hormones in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus. 4th ed. Baltimore: Lea & Febiger; 1993:148-56.
8. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum 1978; 21:480-4.
9. Sanchez-Guerrero J, Liang MH, Karlson EW, et al. Postmenopausal estrogen therapy and the risk of developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
10. Healy E, Kieran E, Rogers S. Cutaneous lupus erythematosus - a study of clinical and laboratory prognostic factors in 65 patients. Irish J Med Sci 1995;164:113-5.
11. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
12. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiology Drug Safety 1992;1:347-9.
13. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
14. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen compounds. Lancet 1995;346:1589-93.
15. Pérez Gutthann S, García Rodríguez LA, Castellsague J, Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997;314:796-800.
16. Anonymous. Anatomical therapeutic chemical index: including defined daily doses for plain substances. Oslo: World Health Organization; 1992.
17. Hay EM, Snaith ML. Systemic lupus erythematosus and lupus-like syndromes. BMJ 1995;310:1257-61.
18. Magaro M, Zoli A, Altomonte L, et al. The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 1992;10:67-70.
19. Boey ML, Fong PH, Lee JS, Ng WY, Thai AC. Autoimmune thyroid disorders in SLE in Singapore. Lupus 1993;2:51-4.
20. Ahmed SA, Penhale WJ, Talal N. Sex hormones, immune responses and autoimmune diseases. Am J Pathol 1985;121:531-51.
21. Arnalich F, Benito-Urbina S, Gonzalez-Gancedo P, Iglesias E, DeMiguel E, Gijon-Banos J. Inadequate production of progesterone in women with systemic lupus erythematosus. Br J Rheumatol 1992;31:247-51.
22. Munoz JA, Gil A, Lopez-Dupla JM, Vazquez JJ, Gonzalez-Gancedo P. Sex hormones in chronic systemic lupus erythematosus. Ann Med Interne 1994;145:459-63.